Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cook Islands Tech Reporter.
Press releases published on September 11, 2025
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Sky Pharm SA, signed a …
authID and MajorKey Technologies Forge Strategic Alliance to Deliver High-Assurance Identity Verification for Microsoft Entra Customers
New partnership brings seamless high-assurance biometric identity verification to Microsoft Entra Suite, combatting the rise in AI-driven fraud. DENVER, Sept. 11, 2025 (GLOBE NEWSWIRE) -- authID (Nasdaq: AUID), a leading provider of biometric identity …
NE2NE Launches PDFFlex to Easily and Accurately Extract Data from Complex PDF Files
CLEVELAND, Sept. 11, 2025 (GLOBE NEWSWIRE) -- True to its mission as the world’s only fully agnostic data integration platform offering affordable, no-code solutions for small-to-midsized businesses, NE2NE today announced the launch of PDFFlex, an AI- …
Biodesix Announces One-for-Twenty Reverse Stock Split
LOUISVILLE, Colo., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX) (“Biodesix” or the “Company”), a leader in personalized diagnostics, today announced a one-for-twenty reverse stock split (the “Reverse Stock Split”) of the Company’s …
ZenaTech Announces the Acquisition of Lescure Engineers Inc. Expanding Drone as a Service (DaaS) to California’s Precision Agriculture and Viticulture Markets
VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), …
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
BRIDGEWATER, N.J, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of Amneal’s sodium oxybate oral solution 500 mg/mL Abbreviated New Drug …
Wearable Devices Announces Pricing of $4 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Yokne’am Illit, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (the “Company” or “Wearable Devices”), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, …
CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical
LAS VEGAS, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced the receipt of an …
BlockQuarry Corp. Introduces BLQCsmith Service Platform, Expanding Revenue Model with Advanced Mining Management Solutions
HOUSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- BlockQuarry Corp. (OTC: BLQC), a leading Texas-based energy and infrastructure company specializing in advanced mining solutions, today announces the development of BLQCsmith, a comprehensive service platform …
Global Mofy AI Launches New Website Domain to Strengthen Global AI Brand Identity
BEIJING, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use …
Rezolve Ai Launches Visual Search, Replacing Keyword Search with Conversational Commerce
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a leader in proprietary AI-powered commerce solutions and a strategic partner of Microsoft and Google, today announced the launch of Visual Search, a transformative capability that …
Enlivex CEO Issues Letter to Shareholders Outlining Strategic Roadmap Following Positive Phase IIa Allocetra™ Results
Allocetra™ demonstrated statistically significant and clinically meaningful improvements in pain and function in Phase IIa trial in primary osteoarthritis patients Six-month data expected November 2025; Phase IIb trial initiation planned for Q2 …
Marquess School of Global Assets and BLUZOR Exchange Unite: Pioneering a New Era of AI and Blockchain-Driven Wealth
Denver, Colorado, Sept. 11, 2025 (GLOBE NEWSWIRE) -- With the rapid rise of blockchain and artificial intelligence, global financial markets are undergoing a transformative digital revolution. From the surge of cryptocurrencies to the widespread adoption …
FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
WEST PALM BEACH, FL, Sept. 11, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the “Company”), announces that it has signed a stock purchase agreement to acquire Vector Biosource Inc. (“Vector”). Vector is an information, data and biospecimen …
Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement
SOUTH SAN FRANCISCO, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today …
Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress
SAN FRANCISCO and BOSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and …
Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (PKU) and Chronic Kidney Disease (CKD)
Phase 1 data in healthy volunteers exceed expectations and support best-in-class potential, enabling Phase 2 advancement for both intended indications of PKU and CKD Dose-dependent urinary amino acid excretion demonstrated across all SAD and MAD cohorts, …
WONZ Technology Showcases Innovative Product WONZ ta-VNS Device at IFA
Berlin, Germany, Sept. 11, 2025 (GLOBE NEWSWIRE) -- At this year's IFA International Consumer Electronics Show, WONZ Technology showcased its latest innovative product – the ta-VNS Device, offering global users a new solution for sleep and health support. …
Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, will present clinical and preclinical data from its …
Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204’s Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration
New Positive Preclinical Data Shows Succesful Drug Distribution to Liver, Peritoneum, and Lung with Measurable Reductions in Tumor Burden at Clinically Relevant Doses Results Provide Further Validation of the Systemic Component of a Dual-Route …